Publications

Show less

Information about journal articles, updated at 18-04-2024, from platform CIÊNCIAVITAE.

Integrative Profiling of Amyotrophic Lateral Sclerosis Lymphoblasts Identifies Unique Metabolic and Mitochondrial Disease Fingerprints

Cunha-Oliveira T; Carvalho M; Sardão V; Ferreiro E; Mena D; Pereira FB; Borges F; Oliveira PJ; Silva FSG, Translational Neurodegeneration. 2022. submitted Translational Neurodegeneration

Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis

Albertini, Claudia; Salerno, Alessandra; Atzeni, Silvia; Uliassi, Elisa; Massenzio, Francesca; Maruca, Annalisa; Rocca, Roberta; et al, ACS Chemical Neuroscience. 2252 - 2260. 15. 13. 2022. http://dx.doi.org/10.1021/acschemneuro.2c00261 . 10.1021/acschemneuro.2c00261 . ACS Chemical Neuroscience

Off-target effects of etomoxir on mitochondrial complex I (In preparation)

Silva FSG; Komlódi T ; Duarte AI; Mena D; Garcia-Souza LF; Makrecka-Kuka M; Bento GJF; et al, 2022.

Liraglutide Protects Against Brain Amyloid-ß1-42 Accumulation in Female Mice with Early Alzheimer´s Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation.

Ana I. Duarte; Emanuel Candeias; Inês N. Alves; Débora Mena; Daniela F. Silva; Nuno J. Machado; Elisa J. Campos; et al, International Journal of Molecular Sciences. 5. 21. 2020. http://dx.doi.org/10.3390/ijms21051746 . 10.3390/ijms21051746 . International Journal of Molecular Sciences

All projects

Show less

Information of exclusive responsibility of the researcher 18-04-2024 , from platform CIÊNCIAVITAE.

2022/07 - 2022/12

MitoBOOST v2.0 - A Proof of Concept for the Use of Mitochondria-Targeted Polyphenols to Treat Non-Alcoholic Fatty Liver Disease

CENTRO-01-0145-FEDER-181226

Other

Funders: Commission for the Coordination and Regional Development of the Center

2022/09 - 2022/12

CôaMedPlants-Preservation of natural and cultural heritage and scientific validation of practices with medicinal plants from Côa Valley

COA/BRB/0019/2019

Other

Funders: FCT - Fundação para a Ciência e Tecnologia

2021/08 - 2021/12

Development of new mitochondria-targeted antioxidants to ameliorate the phenotype of the familial SOD1 amyotrophic lateral sclerosis (MITO4ALS)

PTDC/MED-FAR/29391/2017

Other

2020/09 - 2021/06

Novel mitochondria-targeted antioxidants and oxidative damage in fibroblasts (SKINSHIELD)

POCI-01-0145-FEDER- 028607

Other

Center for Neuroscience and Cell Biology (CNC); Faculty of Sciences, University of Porto, Portugal.

Funders: FCT - Fundação para a Ciência e Tecnologia

2020/09 - 2021/07

Development of new mitochondria-targeted antioxidants to ameliorate the phenotype of the familial SOD1 amyotrophic lateral sclerosis (MITO4ALS)

PTDC/MED-FAR/29391/2017

Other

Center for Neuroscience and Cell Biology (CNC); Faculty of Sciences, University of Porto, Portugal.

Funders: FCT - Fundação para a Ciência e Tecnologia

2019/11 - 2020/08

Strategic Project: Healthy Aging 2020

CENTRO-01-0145- FEDER-000012

Other

Center for Neuroscience and Cell Biology (CNC); University of Coimbra

2019/03 - 2019/12

Targeting huntingtin proteostasis and mitochondria to prevent neuronal dysfunction in Huntington´s disease

grant.Provided by PTCRIS: 139010

Other

Funders: FCT - Fundação para a Ciência e Tecnologia

2018/09 - 2019/09

Brain protection by Evolocumab in individuals at high risk for cardiovascular disease: from bench to bedside

PEPITA

Other

University of Coimbra, Faculty of Medicine

Funders: Banco Santander Totta

We use cookies to improve your visit to our website.